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1. Introduction
The basic concept of gene therapy involves the
treatment of human diseases by transferring genetic
material to specific cell types in order to correct or
supplement defective genes responsible for disease
development [1]. Progress in the clinical develop-
ment of this approach has been hampered by the
inefficient transport of plasmid DNA/oligonu-
cleotides through the cell membrane. Therefore, the
success of gene therapy is largely dependent on the
development of efficient gene delivery vehicles.
There are two types of carriers used in experimental
gene therapy protocols, viral and non-viral vectors,
both of which present specific advantages and dis-
advantages [2]. The search for non-viral vectors
began when viral vectors met with serious draw-
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Abstract. We developed a novel and convenient method for the synthesis of a potentially safe non-viral gene delivery vehi-
cle based on the cationic block copolymer of spermine and aspartic acid (ASSP) and coupled it with polyethylene glycol
(PEG). The copolymer ASSP was prepared by direct polycondensation in the ionic liquid, butylmethylimidazolium hexa-
fluorophosphate, using triphenyl phosphite as the condensing agent under mild reaction conditions. The highly hydropho-
bic ASSP was transformed into a water soluble hydrophilic micelle by coupling ASSP with polyethylene glycol (PEG)
using the same ionic liquid and 1,1-carbonyl diimidazole as the condensing agent without harsh conditions. The polyca-
tionic ASSP-PEG was then used to condense calf thymus and plasmid deoxyribonuclceic acids (DNAs) in Tris-HCl buffer
(pH 7.4) to get a series of block ionomer complexes with various charge ratios. The physicochemical properties of the
copolymer micelle and the DNA polyplexes were studied using fourier transform-infrared (FTIR), nuclear magnetic reso-
nance (NMR) and circular dichroism (CD) spectroscopy, matrix assisted laser desorption/ionization-time of flight mass
spectrometry (MALDI-TOF MS), differential scanning calorimetry (DSC), transmission electron microscopy (TEM) and
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backs such as high risk of mutagenicity, immuno-
genicity, low production yield, and limited ability
to carry long gene sequences [3]. Several approaches
have been tested in order to circumvent problems
associated with each type of non-viral gene deliv-
ery vehicles [4, 5]. The use of polymeric materials
as delivery vehicles has been well established and
widely used to improve therapeutic potential of
peptides, proteins, small molecules and oligonu-
cleotides [6–19].
The cationic molecules which are currently under
development as gene delivery vehicles are organic
cations, including cationic lipids, polyamine-based
polymers, chitosan based polymers, dendrimers,
and polyethyleneimine (PEI) [1, 3, 4, 7–10, 13, 16,
20–24]. The spontaneous formation of polyplexes
by the interaction of negatively charged phosphate
groups of DNA/oligonucleotides and positively
charged polymers under physiological salt condi-
tions and the successful transport of these poly-
plexes to cells has been demonstrated [25–33].
Several investigators have reported encouraging
results on spermine and its chemical analogues
DNA condensing agents for gene therapy applica-
tions [34–38]. Since DNA molecules condensed
with low-molecular weight cations are susceptible
to aggregation under physiological conditions [39],
advanced polymeric gene delivery systems employ
macromolecules, with high cationic charge density,
that can protect the DNA from degradation [40].
So, this has necessitated attempts towards modifi-
cation of spermine with a view to developing high
molecular weight copolymers [40–43].
Jere et al. have reported synthesis of a poly(β-
amino ester) of spermine and poly(ethylene glycol)
(PEG), which showed higher degree of safety and
transfection efficiency in comparison to polyethyl-
eneimine, when studied in 293T human kidney car-
cinoma cells [40]. On the other hand, Vinogradov
et al. [41] reported that poly(ethylene glycol)-sper-
mine complexes are less stable in the presence of
low molecular weight electrolytes compared to the
PEG-PEI complexes. Domb and coworkers [42,
43] showed that dextran grafted spermine improved
cell transfection compared to the unmodified one.
Kanatani et al. [44] showed that pullulan-spermine-
mediated transfection of plasmid DNA resulted in
greatly reduced cytotoxicity and a 10-fold increase
in the level of gene expression when compared to
lipofectamine 2000, a commercially available
cationic lipid. A copolymer of spermine with amino
acids such as aspartic acid and glutamic acid might
present a number of advantages, including biocom-
patibility and biodegradability. The loss of charge
density on copolymerization might be compensated
by the presence of the additional amino group
which could be protected during polymerization.
Coupling the copolymer with hydrophilic com-
pounds, such as PEG, might reduce non-specific
interaction of the copolymer with blood compo-
nents as well as make it water soluble. The goal of
the present work was to synthesize and characterize
a novel cationic polymer based on the naturally
occurring polyamine, spermine and aspartic acid,
using an ionic liquid and triphenyl phosphite as sol-
vent and condensing agent, respectively. Since
ionic liquids have negligible vapor pressure, they
are attractive agents for use as ‘green’ reaction
media and can potentially replace conventional
organic solvents in synthesis and other applica-
tions.
2. Experimental
2.1. Materials
Plasmid DNA, spermine, methyl imidazole HPF6
and chlorobutane (Sigma Aldrich) N-tert-butyloxy-
carbonyl (Boc)-L-aspartic acid, triphenyl phos-
phate, 1,1-carbonyl diimidazole, polyethylene gly-
col metyl ether (MW = 2000) (Aldrich) were used
as received. Calf thymus DNA (molecular weight =
6·106) was obtained from Worthington Biochemi-
cal Corporation, USA. Plasmid pEGFP (3.4 kilo
base pair length), which has the early promoter of
CMV and enhanced green fluorescence protein
(EGFP) gene was obtained from Clontech.
2.2. Preparation of ionic liquids
The ionic liquid butylmethylimidazolium hexafluo-
rophosphate were synthesized according to the lit-
erature [45].
2.3. Copolymerization of Boc-Aspartic acid
and spermine (Boc-ASSP)
Boc-ASSP was prepared by stirring N-Boc-L-aspar-
tic acid (0.001 mol), spermine 4HCl (0.001 mol),
and 3.2 g of ionic liquid at room temperature for
10 min, and 0.52 ml (0.00225 mol) of triphenyl
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phosphite was added. The temperature was gradu-
ally elevated to 100°C under an inert gas atmos-
phere, the reaction mixture was held at this
temperature, and stirring for 2.5 h. Boc-ASSP was
isolated by precipitation in excess methanol. Poly-
mer was thoroughly washed with methanol and
dried in vacuum at 70°C.
2.4. Deprotection of N-BOC fron BOC-ASSP
Manual removal of the N-terminal Boc group can
be accomplished by placing the resin in a RB flask
and washing with 50% [v/v] trifluoroacetic acid
(TFA)/dichloromethane (DCM) for 15 min at room
temperature with constant stirring. After 15 min,
the mixture was extracted with ethyl acetate and
washed with sodium bicarbonate solution and then
with saturated sodium chloride solution. The prod-
uct was the precipitated with methanol.
2.5. Synthesis of PEG–ASPSP
A 1 mmole portion of polyethylene glycol methyl
ether (MW = 2000) was dissolved in 5 ml of ionic
liquid and reacted with 1 mmole of 1,1-carbonyl
diimidazole at 20°C for 3 hours. This reaction mod-
ifies the terminal hydroxyl group of polyethylene
glycol methyl ether. The reaction system was then
supplemented with 1mmole of ASSP and the mix-
ture incubated at 20°C for 16 hours. The product
was then precipitated in DCM and the ionic liquid
is recovered by evaporating the DCM.
2.6. Characterization of ASSP-PEG
NMR spectra of the compound were recorded using
300-MHz Brucker NMR spectrophotometer in D2O.
Infrared spectra of the polymers were recorded
using an IR prestige-21 FT-IR Shimadzu spec-
trophotometer in the range of 4000–400 cm–1. The
thermal stability of the polymers was determined
using DTG-60 Shimadzu thermo- gravimetric ana-
lyzer at a heating rate of 10°C/min in nitrogen. The
thermal transitions of the polymers were deter-
mined using a Perkin-Elmer DSC-7 differential
scanning calorimeter under nitrogen purge. The
samples were heated at a rate of 10°C/min. The
MALDI TOF MS were run using a Micro mass
TofSpec 2E instrument using a nitrogen 337 nm
laser (4 ns pulse). At least 40–50 shots are summed
up. The matrix used is 2,5-dihydroxy benzoic acid
dissolved in water. The sample ASSP is dissolved
in water and the matrix spotted in MALDI target
and allowed to dry before introducing into the mass
spectrometer. The solution of the polymer ASSP
and ASSP-PEG in water was prepared in a concen-
tration of 1 mg/1 ml and the primary amine content
was determined according to the procedure
described elsewhere [45].
2.7. DNA-ASPSP-PEG complex formation
A solution of the polymer ASPSP-PEG in Tris-HCl
buffer (pH 7.4) was prepared at a concentration of
1 μg/μl. Calf thymus and Plasmid DNA solutions
were also prepared in the same buffer in at a con-
centration of ~1 μg/μl. A series of block ionomer
complexes (BIC) at various charge ratios were pre-
pared by mixing ASPSP-PEG solution with a DNA
solution. The mixture was mixed by vortexing for
2–3 min and incubated for 30 min. at room temper-
ature for completing the complex formation. It was
noted that during complex preparation, the volume
of DNA was kept constant and volume of polymer
solution was adjusted for the theoretical charge
ratio. The dispersive stability of the complexes was
evaluated by turbidity measurement at 500 nm
using UV-Vis spectrophotometer (PerkinElmer-
Lamda-35).
2.8. Particle size measurement
The polyplexes were prepared at increasing weight
ratios from 1:0.25 to 1:1.5 (DNA/Polymer) in Tris-
HCl buffer. Ten microgram plasmid DNA was used
and the final volume was set to 2 ml with H2O. A
helium–neon lamp was used as the light source
(10 mW) on a Malvern Zetasizer 3000HAs system
(Malvern Instruments Ltd, Worcestershire, U.K.).
Values were obtained 3 cycles per 10 time meas-
urements.
2.9. Circular Dichroism (CD)
For CD measurement, the chitoplex solutions with
weight ratio from 1:0.25 to 1:1.5 (DNA/Polymer)
were prepared using ASSP-PEG in terms of the
method described above. CD spectra were collected
with a 1 cm path length cuvette using J-810 spec-
tropolarimeter in a range of wavelengths of 350–
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200 nm at 25°C. The spectra were corrected by
subtracting the background of sodium acetate/
acetic acid buffer
2.10. Transmission electron microscopy
(TEM)
Transmission electron microscope (TEM) images
were recorded using a Hitachi H-600 instrument at
75 kV. For TEM measurements a drop of the poly-
plex solution in the weight ratio of 1:1 (10 μg in
1 ml of trisbuffer) were deposited directly of Form-
var coated copper grid.
3. Results and discussion
The present study was aimed to design and evaluate
a novel, potentially safe non-viral gene delivery
vector based on the cationic copolymer of spermine
and aspartic acid using butylmethylimidazolium
hexafluorophosphate ionic liquid as the medium
[45]. Vygodskii et al. [46] have shown that 1,3-
dialkylimidazolium based ionic liquids (IL) are
suitable reaction and activating media for the syn-
thesis of high molecular weight polymers, includ-
ing polyamides. Low temperature solution poly-
condensation of diamines and diacid chlorides was
used for preparing polyamides. The polyamide syn-
thesis was carried out using Boc-aspartic acid and
spermine under mild conditions. N-Boc protection
was removed by washing the polymer with 50%
[v/v] TFA/DCM. As the copolymer (ASSP) was
found to be highly hydrophobic and insoluble in
many of the organic solvents, it was coupled with
PEG, using the same ionic liquid as solvent and
1,1-carbonyl diimidazole as condensing agent (see
Figure 1), to make it hydrophilic and water soluble.
A commercial PEG polymer with one end capped
by a methoxy group was used for this purpose. The
polymers thus obtained (BASSP, ASSP and ASSP-
PEG) were structurally characterized by means of
FTIR spectroscopy (Figure 2). The vanishing of the
peak at 645 cm–1 and enhanced visibility of the
peaks of primary amino group at 3440 cm–1 indi-
cate the effective removal of Boc group from
BASSP. The strong peaks at 843 cm–1 may be due
to the N–H deformation vibrations of aliphatic pri-
mary amines. The peak at 1596 cm–1 is due to the
asymmetric NH3
+ deformation vibration. In addi-
tion, the weakening of the carbonyl peaks at 1726
and 1661 cm–1 might be due to the coupling of PEG
at the acid groups the polymer other than amino
group. Therefore, the amino groups are free for
undergoing electrostatic interaction between the
negatively charged phosphate groups of DNA [47].
We next determined the thermal characteristics of
the copolymers using thermogravimetric analysis
(TGA) and differential scanning calorimetry
(DSC). It can be seen from Table 1 that the polymer
ASSP has the lowest thermal stability due possibly
to the presence of the chain terminal groups
(–COOH and –NH2 ) in comparison to that of
BASS having the thermally stable Boc protecting
group. In contrast, ASSP-PEG has stable chain ter-
minal groups (–OCH3) leading to a higher thermal
stability. Therefore, the observed differences in the
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Figure 1. The chemical structure of polymers BASSP, ASSP, ASSP-PEG
thermal stabilities of the synthesized polymer are
consistent with their structures. The glass transition
temperature and heat of transition of these poly-
mers were determined from DSC data. Table 1
shows that ASSP-PEG exhibited a Tg value between
those of ASSP and BASSP.
ASSP-PEG was soluble in water at a concentration
of 1 µg/1 µl and the primary amine content was
determined using TNBS (Trinitro benzene sul-
phonic acid) method (Table 2, Figure 3). It was
observed that the number of primary amino group
of ASSP-PEG was higher than that of ASSP. It may
be due to the higher solubility of the polymer in
aqueous medium after PEGylation [48]. This result
further confirms that the PEG is coupled to the acid
end group of the polymer, and not to the amino
group. The molecular weight of the polymer was
above 10 kDa as obtained from measurements by
MALDI TOF MS.
A successful gene carrier is one which can effec-
tively condense negatively charged DNA into
nanosized particles [1, 2, 5–7, 47]. The condensa-
tion behaviors were studied by using IR spec-
troscopy, CD spectra, turbidity measurements, par-
ticle size analyzer and TEM. The IR spectrum the
complex of the copolymer with calf thymus DNA
(Figure 4) reveals that as the concentration of poly-
mer increases the intensity of peaks at 1024 cm–1
due to P–O–H stretching vibration goes on decreas-
ing and at the charge ratio of P/N = 1.5, the peaks
are almost vanished. Similar observation was also
found in the case of N–H stretching vibrations of
purines and pyrimidines also. It indicates that as the
concentration of polymer increases, there are no
more negative centers on DNA.
The effect of the condensation of the copolymer
with DNA on the secondary structures of DNA was
evaluated by CD measurement. It can be seen from
Figure 5 that the pure DNA appears in a typical
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Figure 3. Number of primary amino group in µmol/mg
Figure 2. FTIR of polymers
Table-1. TGA and DSC results of the polymers
Polymer 10% wt loss T [°C] Tg [°C] ΔH [J/g]
BASSP 276 157 21
ASSP 234 179 21
ASSP-PEG 276 175 21
Table 2. Amount of primary amino group of the polymers
Polymer Absorbance at 410 nm
Corresponding conc. of
spermine
Corresponding no.
of moles of spermine
No. of 1° NH3 group/μl 
ASSP 0.1098 091.27 2.62·10–7 1.805·1015
ASSP-PEG 0.1271 111.59 3.20·10–7 2.510·1015
Figure 4. FTIR spectra of ASSP-PEG/CTDNA complexes
B conformation with approximately equal positive
(275 nm) and negative (245 nm) components cen-
tered on 258 nm. While plain spermine copolymer
does not show any characteristic pattern, its com-
plexes with DNA show changes in the intensity of
peaks indicating electrostatic interaction with the
negatively charged phosphate groups of DNA [49],
but the ‘Cotton effect’ remains nearly unchanged,
demonstrating that DNA remains in B conforma-
tion upon complexing with ASSP-PEG polymer.
The dispersive stability of ASSP-PEG polymer
–DNA complex was measured using turbidity
measurements in which the increase in turbidity
indicates self-aggregation. Figure 6 shows that at
P/N = 0.5 the turbidity was found to be the least
and on increasing the charge ratio of the polymer,
turbidity goes on increasing. And at the ratio 1:2
turbidity is found to be decreased without precipita-
tion indicating enhanced stability.
The formation of the nanoparticles was confirmed
by measurement of particle size and TEM. The
polyplexes were prepared at increasing weight
ratios from 1:0.25 to 1:1.5 (DNA/Polymer) in Tris-
HCl buffer. Figure 7 shows that the formation of
the complex is inversely related to the charge ratio.
As the charge ratio increases, the size decrease
sharply and becomes a minimum value of 142.5 nm
at charge ratio of 0.75 (P/N = 0.75). The charge
density and the copolymer structure have remark-
able effects on the DNA condensation and size of
the nanoparticles that are formed [5].
Figure 8 exhibits TEM the images of the particles
of plasmid DNA in the charge ratio of P/N = 1.
Toroid like structure with a core-shell arrangement
indicates the formation of the DNA-chitosan
nanoparticle. The particle size value observed in
the TEM micrographs was in the same magnitude
as observed by the particle size analyzer. Thus, our
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Figure 5. CD spectra of ASSP-PEG/CTDNA complexes
Figure 6. Turbidity curve of CTDNA/ASSP-PEG com-
plexes
Figure 7. Polyplex sizes as CTDNA/ASSP-PEG com-
plexes
Figure 8. Electron microscope image of PLDNA/ASSP-
PEG
data indicate that the copolymer ASSP-PEG con-
denses with DNA to form nanoparticles in the size
range reported for safe transfection. The feasibility
in gene transfection by spermine conjugates and
derivatives has been established by a number of
researchers [40–44, 50, 51]. The copolymerization
of spermine with aspartic acid followed by cou-
pling with PEG might be expected to substantially
improve the low transfection efficiency of sper-
mine [6]. This strategy also reduces cytotoxicity
associated high cationic charge of spermine moi-
eties [5]. The incorporation of PEG in gene vectors
in various creative capacities is a widely used strat-
egy for improving the polyplex solubility and
reduce polyplex aggregation and prolong the circu-
lation time [2, 5, 7, 12, 28, 48]. Both spermine and
aspartic acid, being natural materials are biodegrad-
able and its copolymer with an aliphatic amide
bonding is expected to be also biodegradable [50].
4. Conclusions
A novel and convenient method for the synthesis of
a potentially safe non-viral gene delivery vehicle
based on the cationic block copolymer of spermine
and aspartic acid (ASSP) coupled with polyethyl-
ene glycol (PEG) was developed. The polycationic
ASSP-PEG was found to condense with calf thy-
mus and plasmid deoxyribonuclceic acids (DNAs)
in Tris-HCl buffer (pH 7.4) to give a series of block
ionomer complexes with various charge ratios.
Since DNA condensation to nano/micrometer sized
particles are essential for gene delivery, our results
indicate a potential use of the copolymer in gene
delivery applications.
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